A company that holds Zcash digital currency as its main asset while also funding cancer drug research through a subsidiary.
No revenue is reported; the business runs on operating losses of USD -0.04B in 2025, with net income swinging between gains and losses quarter to quarter.
Zcash's privacy technology is unique among major cryptocurrencies, but adoption faces direct competition from Monero and Ethereum's privacy tools, which erode its network advantage.
Key events, in time order
None yet
None yet
No comments yet.
Facts and opinions separated · All items sourced · Not investment advice
